Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
Creator
Haynes, Barton
Edwards, Robert
Borgnia, Mario
Acharya, Priyamvada
Gobeil, Sophie
Henderson, Rory
Hsu, Allen
Janowska, Katarzyna
Kopp, Megan
Mansouri, Katayoun
Parks, Rob
Stalls, Victoria
source
BioRxiv; Medline; PMC
abstract
The coronavirus (CoV) viral host cell fusion spike (S) protein is the primary immunogenic target for virus neutralization and the current focus of many vaccine design efforts. The highly flexible S-protein, with its mobile domains, presents a moving target to the immune system. Here, to better understand S-protein mobility, we implemented a structure-based vector analysis of available β-CoV S-protein structures. We found that despite overall similarity in domain organization, different β-CoV strains display distinct S-protein configurations. Based on this analysis, we developed two soluble ectodomain constructs in which the highly immunogenic and mobile receptor binding domain (RBD) is locked in either the all-RBDs ‘down’ position or is induced to display a previously unobserved in SARS-CoV-2 2-RBDs ‘up’ configuration. These results demonstrate that the conformation of the S-protein can be controlled via rational design and provide a framework for the development of engineered coronavirus spike proteins for vaccine applications.
has issue date
2020-05-18
(
xsd:dateTime
)
bibo:doi
10.1101/2020.05.18.102087
bibo:pmid
32511343
has license
cc-by-nc-nd
sha1sum (hex)
440b1938dfacddd6fc57f375a5c6986c5c7942ab
schema:url
https://doi.org/10.1101/2020.05.18.102087
resource representing a document's title
Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
has PubMed Central identifier
PMC7252579
has PubMed identifier
32511343
schema:publication
bioRxiv
resource representing a document's body
covid:440b1938dfacddd6fc57f375a5c6986c5c7942ab#body_text
is
schema:about
of
named entity 'coronavirus'
named entity 'highly'
named entity 'rational design'
named entity 'RBDs'
named entity 'constructs'
named entity 'structures'
named entity 'similarity'
named entity 'highly'
named entity 'current'
named entity 'mobility'
named entity 'developed'
named entity 'Here'
named entity 'RBDs'
named entity 'protein'
named entity 'protein'
named entity 'virus'
named entity 'structure-based'
named entity 'vaccine'
named entity 'immunogenic'
named entity 'protein structures'
named entity 'spike (S) protein'
named entity 'coronavirus'
named entity 'receptor binding domain'
named entity 'vector analysis'
named entity 'β-CoV'
named entity 'NSEM'
named entity 'immunogen'
named entity 'ectodomain'
named entity 'dose was fractionated'
named entity 'dihedral'
named entity 'conformation'
named entity 'cryo-EM'
named entity 'PDB'
named entity 'cysteine'
named entity '1-up'
named entity 'MERS'
named entity 'receptor binding'
named entity 'ectodomain'
named entity 'NTD'
named entity 'MERS'
named entity 'mutagenesis'
named entity 'NTD'
named entity 'RBD'
named entity 'OC43'
named entity 'C-terminal'
named entity 'protein structure'
named entity 'trimerization'
named entity 'β-sheet'
named entity 'β-CoV'
named entity 'rigid bodies'
named entity 'transmembrane'
named entity 'natural evolution'
named entity 'GenBank'
named entity 'vaccines'
named entity 'protein'
named entity 'NTD'
named entity 'β-CoV'
named entity 'supernatant'
named entity 'SARS-CoV-2'
named entity 'immunogen'
named entity 'SARS'
named entity 'immunogenicity'
named entity 'SARS'
named entity 'murine'
named entity 'β-CoV'
named entity 'RBD'
named entity 'protein'
named entity 'ethane'
named entity 'dihedrals'
named entity 'SARS-2'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 4
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software